Get the Stockscreener App
0.63
41.10%
0.1835
Pre-market:
.56
-0.07
-11.11%
Harvard Bioscience Inc stock is traded at $0.63, with a volume of 306.72M.
It is up +41.10% in the last 24 hours and up +43.25% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.4465
Open:
$0.5732
24h Volume:
306.72M
Relative Volume:
57.46
Market Cap:
$28.05M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-3.15
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+56.02%
1M Performance:
+43.25%
6M Performance:
+70.32%
1Y Performance:
-74.29%
1-Day Range:
$0.5235
$0.94
1-Week Range:
$0.3952
$0.94
52-Week Range:
$0.2813
$2.82
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.63 | 19.88M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
530.02 | 190.57B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.38 | 52.03B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
252.26 | 37.01B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.26 | 36.39B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
278.54 | 20.49B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Will Harvard Bioscience Inc. stock benefit from sector rotationTrade Ideas & Daily Profit Maximizing Tips - newser.com
Is Harvard Bioscience Inc. stock a contrarian buy2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Using fundamentals and technicals on Harvard Bioscience Inc.2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Why Harvard Bioscience Inc. stock is seen as undervaluedJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Can Harvard Bioscience Inc. stock hit analyst price targetsJuly 2025 PreEarnings & Consistent Profit Trading Strategies - newser.com
Will Harvard Bioscience Inc. (HBI) stock benefit from mergersInsider Buying & Verified Entry Point Detection - newser.com
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround? - ts2.tech
Key resistance and support levels for Harvard Bioscience Inc.July 2025 Summary & Proven Capital Preservation Methods - newser.com
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET - The Manila Times
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 ... - Bluefield Daily Telegraph
Harvard Bioscience (Nasdaq: HBIO) schedules earnings call to discuss Q3 2025 results - Stock Titan
Is Harvard Bioscience Inc. stock a buy before product launchesMarket Sentiment Review & Accurate Buy Signal Alerts - newser.com
Published on: 2025-10-30 04:49:01 - newser.com
Will Harvard Bioscience Inc. stock outperform Nasdaq indexJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
Applying Wyckoff theory to Harvard Bioscience Inc. stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
What moving averages say about Harvard Bioscience Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - newser.com
Why Harvard Bioscience Inc. (HBI) stock could break out in 2025Weekly Trade Summary & Reliable Momentum Entry Alerts - Fundação Cultural do Pará
Gains Recap: Is Harvard Bioscience Inc. stock a top pick in earnings season2025 Big Picture & Proven Capital Preservation Methods - Fundação Cultural do Pará
What analysts say about Harvard Bioscience Inc stockMarket Volatility Update & High Return Capital Gain - earlytimes.in
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
14.54%
4.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):